帕金森病和相关疾病之间的血液和脑脊液的差异
Jie Ma1, Zhijian Tang1, Yaqi Wu1
1Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cellular and molecular neurobiology
|December 27, 2024
概括
从类似的条件区分早期帕金森病 (PD) 是具有挑战性的. 本综述强调了血液和脑脊液 (CSF) 的生物标志物,用于准确的差异诊断,转向基于生物标志物的方法.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物研究 生物标志物研究
- 神经学 神经学
背景情况:
- 帕金森病 (PD) 的早期诊断因症状重叠与非典型帕金森综合征 (APS),血管帕金森症 (VP) 和基本震 (ET) 而复杂化.
- 随着帕金森病痴呆症 (PDD) 的发展,在后期阶段,差异诊断变得更加具有挑战性,特别是将其与勒维体痴呆症 (DLB) 区分开来.
- 目前PD的诊断方法严重依赖于症状评估和治疗反应,这可能不可靠.
研究的目的:
- 倡导转向基于生物标志物诊断的范式转变,以区分PD与相关的神经疾病.
- 审查血液和脑脊液 (CSF) 生物标志物在PD和相关疾病的差异诊断中的潜力.
- 探索新兴的分子测量方法,对PD生物标志物具有高诊断性能.
主要方法:
- 审查最近在识别PD的血液和CSF生物标志物的进展.
- 在PD和相关疾病中分析生物标志物度 (例如α-synuclein, lysosomal酶,脂肪酸结合蛋白,神经纤维光链).
- 对诊断生物标志物的分子测量新兴技术的评估.
主要成果:
- 几种血液和CSF生物标志物显示了PD和相关疾病之间的度差异.
- 并非所有已识别的分子都能有效地将PD与所有相关疾病区分开来.
- 生物标志物可以反映潜在的疾病多样性,并有助于了解疾病机制.
结论:
- 基于生物标志物的诊断方法对于准确区分PD与APS,VP,PDD和DLB等疾病至关重要.
- 为了临床应用,需要进一步研究和验证特定的生物标志物和测量技术.
- 生物标志物为改善诊断准确性和了解神经退行性疾病的机制提供了一个有希望的途径.
相关概念视频
Parkinson's Disease: Overview
303
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
303
Neural Regulation
38.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
38.9K
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Cerebrospinal Fluid
1.4K
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
1.4K
Disorders of the Nervous Tissue
926
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
926
The Blood-brain Barrier
46.2K
Overview
46.2K


